Moorestown, New Jersey, United States

7322321334

seeking biotech alpha

seeking biotech alpha 1/20/2020 the heart of biotech™

seeking biotech alpha 1/20/2020 the heart of biotech™

seeking biotech alpha 1/20/2020 the heart of biotech™seeking biotech alpha 1/20/2020 the heart of biotech™seeking biotech alpha 1/20/2020 the heart of biotech™

38th Annual J.P. Morgan Healthcare Conference Slideshows

ACADIA Pharmaceuticals Inc. (ACAD)

image244

  

ACADIA Pharmaceuticals (ACAD) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 15, 2020 6:06 PM ET|3 comments | About: ACADIA Pharmaceuticals Inc. (ACAD) ) 

Amgen Inc. (AMGN)

image245

 

Amgen (AMGN) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 15, 2020 6:13 PM ET | About: Amgen Inc. (AMGN) 

EXACT Sciences Corporation (EXAS)

image246

  

Exact Sciences (EXAS) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 16, 2020 1:51 PM ET  | About: Exact Sciences Corporation (EXAS) 



Moderna, Inc. (MRNA)

image247

 

Moderna (MRNA) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 15, 2020 3:27 PM ET|3 comments  | About: Moderna, Inc. (MRNA) 

Alexion Pharmaceuticals, Inc. (ALXN)

image248

 

Alexion Pharmaceuticals (ALXN) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 15, 2020 3:27 PM ET | About: Alexion Pharmaceuticals, Inc. (ALXN) 

Insulet Corporation (PODD)

image249

 

Insulet Corporation (PODD) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 15, 2020 1:45 PM ET | About: Insulet Corporation (PODD) 

38th Annual J.P. Morgan Healthcare Conference Slideshows

Amarin Corporation plc (AMRN)

image250

 

Amarin (AMRN) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 17, 2020 9:31 AM ET | About: Amarin Corporation plc (AMRN) 

BriaCell Therapeutics Corp. (BCTXF)

image251

 

BriaCell Therapeutics (BCTXF) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 16, 2020 3:11 PM ET | About: BriaCell Therapeutics Corp. (BCTXF) 

Editas Medicine, Inc. (EDIT)

image252

 

Editas Medicine (EDIT) Investor Presentation - Slideshow

Jan. 16, 2020 2:00 PM ET  | About: Editas Medicine, Inc. (EDIT)
 

Stemline Therapeutics, Inc. (STML)

image253

 

Stemline Therapeutics (STML) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 16, 2020 1:59 PM ET  | About: Stemline Therapeutics, Inc. (STML) 

BeiGene, Ltd. (BGNE)

image254

 

Beigene (BGNE) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 16, 2020 1:53 PM ET | About: BeiGene, Ltd. (BGNE) 

Agilent Technologies, Inc. (A)

image255

 

Agilent Technologies (A) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 15, 2020 6:10 PM ET | About: Agilent Technologies, Inc. (A) 

37th Annual J.P. Morgan Healthcare Conference Slideshows

CVS Health Corporation (CVS)

image256

 

CVS Health Corporation (CVS) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 15, 2020 12:57 PM ET|7 comments | About: CVS Health Corporation (CVS) 

ImmunoGen, Inc. (IMGN)

image257

 

ImmunoGen (IMGN) Investor Presentation - Slideshow

Jan. 16, 2020 1:30 PM ET | About: ImmunoGen, Inc. (IMGN) 

Karuna Therapeutics, Inc. (KRTX)

image258

 

Karuna Therapeutics (KRTX) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 17, 2020 11:16 AM ET | About: Karuna Therapeutics, Inc. (KRTX) 

ABIOMED, Inc. (ABMD)

image259

 

Abiomed (ABMD) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 17, 2020 11:07 AM ET | About: Abiomed, Inc. (ABMD) 

Boston Scientific Corporation (BSX)

image260

 

Boston Scientific (BSX) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 15, 2020 6:05 PM ET  | About: Boston Scientific Corporation (BSX)  

Becton, Dickinson and Company (BDX)

image261

 

Becton Dickinson (BDX) Presents At 38th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 15, 2020 6:09 PM ET  | About: Becton, Dickinson and Company (BDX) 

image262

Mapped: The World’s Top 10 Cities in 2035

Published 2 days ago on October 18, 2019By Iman Ghosh

 

Mapped: Where Will The Top 10 Cities Be in 2035?


 

Top 10 Cities by Projected GDP


 

Top 10 Cities by Future Population

 

 

Top 10 Cities By Estimated Annual GDP Growth


 https://www.visualcapitalist.com/top-10-cities/ 

Mapped: The World’s Top 10 Cities in 2035Published 2 days ago on October 18, 2019By Iman Ghosh

 

Mapped: The World’s Top 10 Cities in 2035

Published 2 days ago on October 18, 2019

By


 

https://www.visualcapitalist.com/top-10-cities/ 


 

Weighing The Week Ahead: Earnings Season Opportunities

Oct. 20, 2019 6:55 AM ET|28 comments  | Includes: BAPR, BAUG, BIBL, BJUL, BJUN, BOCT, CHGX, CRF, DDM, DIA, DMRL, DOG, DUSA, DXD, EDOW, EEH, EPS, EQL, EQWL, ESGL, FEX, FWDD, GSEW, HUSV, IVV, IWL, IWM, JHML, JKD, OMFS, OTPIX, PAPR, PAUG, PJAN, PJUN, PMOM, PPLC, PSQ, QID, QLD, QQEW, QQQ, QQQE, QQXT, RSP, RVRS, RWL, RWM, RWSL, RYARX, RYRSX, SCAP, SCHX, SDOW, SDS, SFLA, SFY, SH, SMLL, SPDN, SPLX, SPSM, SPUU, SPXE, SPXL, SPXN, SPXS, SPXT, SPXU, SPXV, SPY, SQQQ, SRTY, SSO, SSPY, SYE, TNA, TQQQ, TRND, TWM, TZA, UAUG, UDOW, UDPIX, UJAN, UOCT, UPRO, URTY, USA, USMC, UWM, VFINX, VOO, VTWO, VV, ZFJeff MillerValue, Growth 


 https://seekingalpha.com/article/4297479-weighing-week-ahead-earnings-season-opportunities 

2019 Q3 - Results

Intercept Pharmaceuticals, Inc. (ICPT)

image263

 

Intercept Pharmaceuticals, Inc. 2019 Q3 - Results - Earnings Call Presentation

Nov. 5, 2019 11:26 AM ET | About: Intercept Pharmaceuticals, Inc. (ICPT) 

Neurocrine Biosciences, Inc. (NBIX)

image264

 

Neurocrine Biosciences, Inc. 2019 Q3 - Results - Earnings Call Presentation

Nov. 5, 2019 7:48 AM ET | About: Neurocrine Biosciences, Inc. (NBIX) 

: Amarin Corporation plc (AMRN)

image265

 

Amarin Corporation plc 2019 Q3 - Results - Earnings Call Presentation

Nov. 5, 2019 3:32 PM ET  | About: Amarin Corporation plc (AMRN) 

Becton, Dickinson and Company (BDX)

image266

 

Becton, Dickinson and Company 2019 Q4 - Results - Earnings Call Presentation

Nov. 5, 2019 3:32 PM ET|1 comment | About: Becton, Dickinson and Company (BDX) 

QIAGEN N.V. (QGEN)

image267

 

QIAGEN N.V. 2019 Q3 - Results - Earnings Call Presentation

Nov. 5, 2019 2:28 PM ET | About: QIAGEN N.V. (QGEN) 

IN.PACT™ Admiral™ DCB

image268

 

Four-Year Data from the IN.PACT Global Study Highlight Durable Performance and Safety of IN.PACT™ Admiral™ DCB

Tue November 5, 2019 1:15 PM|GlobeNewswire|About: MDT

Longest-Term Data from a Real-World PAD Patient Population Presented at VIVA

DUBLIN and LAS VEGAS, Nov. 05, 2019 (GLOBE NEWSWIRE) --  Medtronic plc (MDT)

2019 Q3 - Results

Celgene Corporation (CELG)

image269

 

Celgene Corporation 2019 Q3 - Results - Earnings Call Presentation

Nov. 1, 2019 11:58 AM ET|5 comments | About: Celgene Corporation (CELG) 

Exelixis, Inc. (EXEL)

image270

 

Exelixis, Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 31, 2019 3:51 PM ET|1 comment | About: Exelixis, Inc. (EXEL) 

Sanofi (SNY)

image271

 

Sanofi 2019 Q3 - Results - Earnings Call Presentation

Oct. 31, 2019 1:57 PM ET | About: Sanofi (SNY) 

bluebird bio, Inc. (BLUE)

image272

 

bluebird bio (BLUE) Investor Presentation - Slideshow

Nov. 2, 2019 2:03 PM ET|1 comment | About: bluebird bio, Inc. (BLUE) 

GlaxoSmithKline plc (GSK)

image273

 

GlaxoSmithKline plc 2019 Q3 - Results - Earnings Call Presentation

Oct. 30, 2019 10:13 AM ET | About: GlaxoSmithKline plc (GSK) 

Vertex Pharmaceuticals Incorporated (VRTX)

image274

 

Vertex Pharmaceuticals Incorporated 2019 Q3 - Results - Earnings Call Presentation

Nov. 3, 2019 10:53 PM ET | About: Vertex Pharmaceuticals Incorporated (VRTX) 

2019 Q3 - Results

Merck & Co., Inc. (MRK)

image275

 

Merck & Co., Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 29, 2019 8:34 AM ET | About: Merck & Co., Inc. (MRK) 



Pfizer Inc. (PFE)

image276

 

Pfizer Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 29, 2019 7:26 AM ET  | About: Pfizer Inc. (PFE) 



Incyte Corporation (INCY)

 

Incyte Corporation 2019 Q3 - Results - Earnings Call Presentation

Oct. 29, 2019 9:32 AM ET | About: Incyte Corporation (INCY) 



Amgen Inc. (AMGN)

image277

 

Amgen Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 29, 2019 4:59 PM ET | About: Amgen Inc. (AMGN) 

NovoCure Limited (NVCR)

image278

NovoCure Limited 2019 Q3 - Results - Earnings Call Presentation

Oct. 31, 2019 12:28 PM ET  | About: NovoCure Limited (NVCR) 

Seattle Genetics, Inc. (SGEN)

image279

 

Seattle Genetics, Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 29, 2019 8:04 PM ET | About: Seattle Genetics, Inc. (SGEN) 

2019 Q3 - Results

Thermo Fisher Scientific Inc. (TMO)

image280

 

Thermo Fisher Scientific Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 23, 2019 9:57 AM ET | About: Thermo Fisher Scientific Inc. (TMO) 

Novartis AG (NVS)

image281

 

Novartis AG 2019 Q3 - Results - Earnings Call Presentation

Oct. 22, 2019 6:53 AM ET | About: Novartis AG (NVS) 

Amarin Corporation plc (AMRN)

image282

 

Amarin Corporation (AMRN) Investor Presentation - Slideshow

Oct. 3, 2019 10:59 AM ET|11 comments  | About: Amarin Corporation plc (AMRN) 

AstraZeneca PLC (AZN)

image283

 

AstraZeneca PLC 2019 Q3 - Results - Earnings Call Presentation

Oct. 24, 2019 10:19 AM ET | About: AstraZeneca PLC (AZN) 



Gilead Sciences, Inc. (GILD)

image284

 

Gilead Sciences, Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 24, 2019 4:31 PM ET|1 comment  | About: Gilead Sciences, Inc. (GILD) 

Illumina, Inc. (ILMN)

image285

 

Illumina, Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 24, 2019 6:25 PM ET|2 comments | About: Illumina, Inc. (ILMN) 

2019 Q3 - Results

Boston Scientific Corporation (BSX)

image286

 

Boston Scientific Corporation 2019 Q3 - Results - Earnings Call Presentation

Oct. 23, 2019 8:21 AM ET | About: Boston Scientific Corporation (BSX) 

Alkermes plc (ALKS)

image287

 

Alkermes plc 2019 Q3 - Results - Earnings Call Presentation

Oct. 23, 2019 7:57 AM ET | About: Alkermes plc (ALKS) 

About: Alexion Pharmaceuticals, Inc. (ALXN)

image288

 

Alexion Pharmaceuticals, Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 23, 2019 9:59 AM ET | About: Alexion Pharmaceuticals, Inc. (ALXN) 

Veracyte, Inc. (VCYT)

image289

 

Veracyte, Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 23, 2019 12:37 AM ET | About: Veracyte, Inc. (VCYT) 

Eli Lilly and Company (LLY)

image290

 

Eli Lilly and Company 2019 Q3 - Results - Earnings Call Presentation

Oct. 23, 2019 10:01 AM ET | About: Eli Lilly and Company (LLY) 

Biogen Inc. (BIIB)

image291

 

Biogen Inc. 2019 Q3 - Results - Earnings Call Presentation

Oct. 22, 2019 7:13 AM ET  | About: Biogen Inc. (BIIB) 

BAC Global HealthCare Conference & ESMO Congress 2019

Incyte Corporation (INCY)

image292

 

Incyte Corporation (INCY) Presents At Bank of America Merrill Lynch Global Healthcare Conference - Slideshow

Sep. 19, 2019 10:11 AM ET | About: Incyte Corporation (INCY) 

About: Amgen Inc. (AMGN)

image293

 

Amgen Inc. (AMGN) Management Presents at The Bank of America Merrill Lynch Global Healthcare Conference (Transcript)

Sep. 18, 2019 9:01 AM ET | About: Amgen Inc. (AMGN) 

Amgen Inc. (AMGN)

image294

 

Amgen (AMGN) Presents At ESMO Congress 2019 - Slideshow

Oct. 2, 2019 12:20 PM ET | About: Amgen Inc. (AMGN) 

: Novartis AG (NVS)

image295

 

Novartis AG (NVS) Updates on Kisqali® MONALEESA-3 ESMO Data - Slideshow

Oct. 1, 2019 1:15 PM ET | About: Novartis AG (NVS) 

Bristol-Myers Squibb Company (BMY)

image296

Bristol-Myers Squibb (BMY) Presents At ESMO Congress 2019 - Slideshow

Sep. 30, 2019 3:34 PM ET | About: Bristol-Myers Squibb Company (BMY) 

AstraZeneca PLC (AZN)

image297

 

AstraZeneca Group (AZN) Presents At ESMO Congress 2019 - Slideshow

Oct. 2, 2019 12:06 PM ET | About: AstraZeneca PLC (AZN) 

Wainwright 21st Annual Global Investment Conference

CytoDyn (CYDY)

image298

 

CytoDyn (CYDY) Investor Presentation - Slideshow

Sep. 16, 2019 12:51 PM ET | About: CytoDyn Inc. (CYDY) 

Sesen Bio, Inc. (SESN)

image299

 

Sesen Bio (SESN) Presents At H.C. Wainwright 21st Annual Global Investment Conference - Slideshow

Sep. 16, 2019 1:51 PM ET | About: Sesen Bio, Inc. (SESN) 

GW Pharmaceuticals plc (GWPH)

image300

 

GW Pharmaceuticals (GWPH) Investor Presentation - Slideshow

Sep. 16, 2019 1:53 PM ET | About: GW Pharmaceuticals plc (GWPH) 

ProBeam 360 Proton Therapy System

image301

 

Varian Announces Multi-room Configuration for ProBeam 360 Proton Therapy System

Mon September 16, 2019 8:00 AM|PR Newswire|About: VAR

PALO ALTO, Calif., Sept. 16, 2019 /PRNewswire/ -- Varian (VSEA) (NYSE: VAR)

Phase I/IIa clinical trial of Bria-IMT™, BriaCell’s lead candidate, with pembrolizumab [KEYTRUDA®;

image302

 

BriaCell to Present September 19th at 2nd Annual Next Gen Immuno-Oncology Congress in Philadelphia

Mon September 16, 2019 6:30 AM|GlobeNewswire|About: BCTXF, INCY, MRK

BERKELEY, Calif., Sept. 16, 2019 (GLOBE NEWSWIRE) -- BriaCell Therapeutics Corp. (BCTXF) ("BriaCell" or the "Company") (TSX-V:BCT) (OTCQB:BCTXF)

VCF Care Pathway

image303

 

National Osteoporosis Foundation Supports New Evidence-Based Care Pathway Designed to Optimize Care for Vertebral Compression Fractures (VCF)

Mon September 16, 2019 10:00 AM|GlobeNewswire|About: MDTGlobeNewswire

DUBLIN, Sept. 16, 2019 (GLOBE NEWSWIRE) -- Medtronic plc (MDT)

earnings Call Slides Q2./HY 2019

EPS of $0.60495522880967928366 beats by $0.01 Revenue of $4.51B (5.61% Y/Y) beats by $84.19M

image304

 

Novo Nordisk A/S 2019 Q2 - Results - Earnings Call Slides

Aug. 14, 2019 3:43 PM ET | About: Novo Nordisk A/S (NVO) 

Insulet Corporation (PODD)

image305

 

Insulet (PODD) Presents At Canaccord Genuity Growth Conference - Slideshow

Aug. 13, 2019 2:31 PM ET | About: Insulet Corporation (PODD) 

China Biologic Products Holdings, Inc. (CBPO)

image306

 

China Biologic Products Holdings, Inc. 2019 Q2 - Results - Earnings Call Slides

Aug. 7, 2019 12:12 PM ET | About: China Biologic Products Holdings, Inc. (CBPO) .

CRISPR Therapeutics AG (CRSP)

 

CRISPR Therapeutics (CRSP) Investor Presentation - Slideshow

Aug. 13, 2019 2:26 PM ET|2 comments  | About: CRISPR Therapeutics AG (CRSP) 

EPS of $-0.26 beats by $0.09 Revenue of $17.55M (-18.06% Y/Y) beats by $3.96M

image307

 

Sangamo Therapeutics, Inc. 2019 Q2 - Results - Earnings Call Slides

Aug. 13, 2019 1:47 PM ET | About: Sangamo Therapeutics, Inc. (SGMO) 

EPS of $-0.25 beats by $0.04 Revenue of $35.99M (-20.52% Y/Y) beats by $6.37M

image308

 

Intrexon Corporation 2019 Q2 - Results - Earnings Call Slides

Aug. 9, 2019 6:29 PM ET | About: Intrexon Corporation (XON) 

earnings Call Slides Q2./HY 2019

EPS of $2.86 beats by $0.24 Revenue of $4.4B (15.36% Y/Y) beats by $175.57M

image309

 

Celgene Corporation 2019 Q2 - Results - Earnings Call Slides

Jul. 31, 2019 1:34 PM ET | About: Celgene Corporation (CELG) 

Amarin Corporation plc (AMRN)

 

Amarin Corporation plc 2019 Q2 - Results - Earnings Call Slides

Jul. 31, 2019 10:18 AM ET  | About: Amarin Corporation plc (AMRN) 

EPS of $-0.05 beats by $0.04 Revenue of $30.14M (32.46% Y/Y) beats by $1.3M

image310

 

Veracyte, Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 31, 2019 3:06 PM ET | About: Veracyte, Inc. (VCYT) 

Abiomed, Inc. (ABMD)

 

Abiomed, Inc. 2020 Q1 - Results - Earnings Call Slides

Aug. 1, 2019 10:03 AM ET | About: Abiomed, Inc. (ABMD) 

Becton, Dickinson and Company (BDX)

image311

 

Becton, Dickinson and Company 2019 Q3 - Results - Earnings Call Slides

Aug. 6, 2019 10:16 AM ET | About: Becton, Dickinson and Company (BDX) 

Vertex Pharmaceuticals Incorporated (VRTX)

image312

 

Vertex Pharmaceuticals Incorporated 2019 Q2 - Results - Earnings Call Slides

Jul. 31, 2019 4:58 PM ET | About: Vertex Pharmaceuticals Incorporated (VRTX) 

earnings Call Slides Q2./HY 2019

Incyte Corporation (INCY)

image313

 Incyte Corporation 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 7:26 AM ET  | About: Incyte Corporation (INCY) 

Merck & Co., Inc. (MRK)

image314

 Merck & Co., Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 10:14 AM ET|1 comment | About: Merck & Co., Inc. (MRK) 

Bayer Aktiengesellschaft (BAYZF)

image315

 Bayer Aktiengesellschaft 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 6:39 AM ET | About: Bayer Aktiengesellschaft (BAYZF) 

Amgen Inc. (AMGN)

image316

 Amgen Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 7:25 PM ET | About: Amgen Inc. (AMGN) 



 http://investors.amgen.com/static-files/e1393dc2-f372-4dcc-992a-afc36a03b8fa 

Gilead Sciences, Inc. (GILD)

image317

 Gilead Sciences, Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 4:57 PM ET|2 comments | About: Gilead Sciences, Inc. (GILD) 

Neurocrine Biosciences, Inc. (NBIX)

image318

Neurocrine Biosciences, Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 2:37 PM ET|1 comment | About: Neurocrine Biosciences, Inc. (NBIX) 

earnings Call Slides Q2./HY 2019

Pfizer Inc. (PFE)

image319

 Pfizer Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 29, 2019 12:06 PM ET | About: Pfizer Inc. (PFE) 

EPS of $0.72834 beats by $0.01 Revenue of $9.6B (0.40% Y/Y) beats by $228.28M

image320

 Sanofi 2019 Q2 - Results - Earnings Call Slides

Jul. 29, 2019 10:04 AM ET | About: Sanofi (SNY) 

EPS of $9.15 beats by $1.62 Revenue of $3.62B (7.75% Y/Y) beats by $142.47M

image321

 Biogen Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 23, 2019 12:39 PM ET|1 comment | About: Biogen Inc. (BIIB) 

Exact Sciences Corporation (EXAS)

image322

 Exact Sciences Corporation 2019 Q2 - Results - Earnings Call Slides

Jul. 29, 2019 2:01 PM ET | About: Exact Sciences Corporation (EXAS) 

EPS of $1.35 beats by $0.01 Revenue of $838M (0.96% Y/Y) beats by $2.88M

image323

 Illumina, Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 7:07 AM ET | About: Illumina, Inc. (ILMN) 

Eli Lilly and Company (LLY)

image324

 Eli Lilly and Company 2019 Q2 - Results - Earnings Call Slides

Jul. 30, 2019 10:15 AM ET | About: Eli Lilly and Company (LLY) 

earnings Call Slides Q2./HY 2019

EPS of $0.365 beats by $0.06 Revenue of $5.82B (12.96% Y/Y) beats by $251.68M

image325

 

AstraZeneca PLC 2019 Q2 - Results - Earnings Call Slides

Jul. 25, 2019 10:01 AM ET | About: AstraZeneca PLC (AZN) 

EPS of $-0.24 beats by $0.19 Revenue of $218.45M (28.37% Y/Y) beats by $28.69M

image326

 

Seattle Genetics, Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 17, 2019 1:58 PM ET  | About: Seattle Genetics, Inc. (SGEN) 

EPS of $1.32 beats by $0.19 Revenue of $825.8M (16.46% Y/Y) beats by $63.51M

image327

 

Varian Medical Systems, Inc. 2019 Q2 - Results - Earnings Call Slides

Jul. 25, 2019 2:07 PM ET | About: Varian Medical Systems, Inc. (VAR) 

NovoCure Limited (NVCR)

image328

  

NovoCure Limited 2019 Q2 - Results - Earnings Call Slides

Jul. 25, 2019 11:37 AM ET | About: NovoCure Limited (NVCR) 

Alkermes plc (ALKS)

image329

 

Alkermes plc 2019 Q2 - Results - Earnings Call Slides

Jul. 25, 2019 8:19 AM ET | About: Alkermes plc (ALKS) 

Roche Holding AG (RHHBY)

image330

 

Roche Holding AG 2019 Q2 - Results - Earnings Call Slides

Jul. 25, 2019 8:17 AM ET  | About: Roche Holding AG (RHHBY) 

37th Annual J.P. Morgan Healthcare Conference Slideshows

Regeneron Pharmaceuticals, Inc. (REGN)

image331

 Regeneron Pharmaceuticals (REGN) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 7, 2019 2:57 PM ET | About: Regeneron Pharmaceuticals, Inc. (REGN) 

Celgene Corporation (CELG)

image332

 Celgene (CELG) To Present At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 7, 2019 12:43 PM ET | About: Celgene Corporation (CELG) 

Amgen Inc. (AMGN)

image333

 Amgen (AMGN) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 8, 2019 11:42 AM ET  | About: Amgen Inc. (AMGN) 

BioMarin Pharmaceutical Inc. (BMRN)

image334

 BioMarin Pharmaceutical (BMRN) To Present At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 7, 2019 12:45 PM ET  | About: BioMarin Pharmaceutical Inc. (BMRN) 

Illumina, Inc. (ILMN)

image335

 Illumina, Inc. (ILMN) Presents at J.P. Morgan Healthcare Conference - Slide Show

Jan. 7, 2019 8:10 PM ET|9 comments  | About: Illumina, Inc. (ILMN) 

Allergan plc (AGN)

 Allergan (AGN) Presents At 37th Annual J.P. Morgan Healthcare Conference - Slideshow

Jan. 8, 2019 1:19 PM ET|2 comments | About: Allergan plc (AGN) 

©2018 MarketsandMarkets Research Private Ltd.

Biomarker Technologies Market

image336

 Biomarker Technologies Market by Profiling Technology (Chromatography, NGS, PCR, Mass Spectrometry, Immunoassay, Liquid Biopsy (ddPCR, DHPLC)), Research Area (Proteomics, Lipidomics), Application (Biomarker Validation, Biomarker Discovery) - Global Forecast to 2022

Efficacy Testing Market

image337

 Efficacy Testing Market by Product and Service (Consumables, Services), Type (Antimicrobial Efficacy Testing, Disinfectant Efficacy Testing), Application (Pharmaceutical Manufacturing, Cosmetic & Personal Care Products) - Global Forecast to 2022

Oncology Information System Market

image339

 Oncology Information System Market by Software (Patient Information System & TPS), & Professional Service), Application (Medical, Radiation, & Surgical Oncology), End User (Hospital, Government Institution, & Research Center) - Global Forecasts to 2019

Non Invasive Prenatal Testing (NIPT) Market

image340

 Non Invasive Prenatal Testing (NIPT) Market by Instruments (Ultrasound, NGS, PCR, Microarray), Consumables, Method (FCMB, cf-DNA), Application (Trisomy, Microdeletion, Genetics, Rh factor) & End User (Hospital, Diagnostic Labs) - Global Forecast to 2021

Bioinformatics Market

image341

 Bioinformatics Market by Product & Service (Knowledge Management Tools, Data Analysis Platforms (Structural & Functional), Services), Applications (Genomics, Proteomics & Metabolomics), & Sectors (Medical, Academics, Agriculture) - Global Forecast to 2023

©2018 BlackRock, Inc. All Rights Reserved.

image342

Sep 25, 2018 By Bob Miller, Rick Rieder

 An exceptionally strong labor market and reasonably firm inflation
have the Fed monitoring the heat in the U.S. economy. 


image343

  September 2018 - 

BlackRock Investment Institute 

We see a growing disconnect between waning market attention to our top 10 geopolitical risks and the likelihood of some of them escalating. Our global BlackRock Geopolitical Risk Indicator (BGRI) has declined since our last update, suggesting the market’s attention to geopolitical risks overall has edged down. Yet the overall reading masks considerable dispersion, and we have raised the likelihood of three of our risks.Global trade tensions is our focus risk this month as U.S. trade disputes with major trading partners carry on. 

image344

 Sep 19, 2018 -  By Russ Koesterich 

 At $3.5 trillion per year, total healthcare spending (public and private) makes up roughly 20% of the U.S. economy. The nation’s 80 million baby boomers provide a stable source of ongoing revenue growth for healthcare companies throughout the value chain. Demographic tailwinds are widely expected to continue to propel this secular story in the United States. 

image345

 Sep 14, 2018 By Michael Fredericks

 In the United States, we continue to observe above-trend fundamental data, including strong corporate earnings, capital expenditures (business investment) and consumer sentiment. U.S. stocks notably outperformed international markets, with the S&P 500 Index rallying over 3% in August whereas European equities, for instance, were negative. We believe U.S. outperformance will likely persist in the near-term, underscoring our preference for more domestic-oriented assets. 

image346

 Oct 1, 2018

By BlackRock Investment Institute

 We see the steady global expansion rolling on, underpinned by above-trend U.S. growth. Yet the range of potential economic outcomes is widening. Gradual increases in U.S. rates are tightening financial conditions globally, and have contributed to bouts of volatility and sharply depreciating emerging market (EM) currencies. We also take a deep dive into the prospects for EMs after an unexpectedly drawn-out selloff. 

image347

 Oct 8, 2018 By Richard Turnill

 Global equities’ nearly decade-long bull run is stoking anxiety about its ability to power on. One concern: narrow breadth — a fragile state when a small group of stocks is contributing the lion’s share of market returns, buoying the broader index. We see today’s strong equity performance, especially in the U.S., as broad-based and driven by healthy fundamentals and solid earnings momentum. 

© 2018 Grand View Research, Inc. All rights reserved.

image348

 Posted On Sep, 05, 2018

Cancer Biomarkers Market: Increasing demand for rapid and specific cancer diagnosis

 

image349

Posted On Sep, 05, 2018 

Regenerative Medicine: Presence of strong product pipeline coupled with emerging applications in gene therapy projected to drive market


image351

Posted On Sep, 05, 2018

 Biosimilars - A Pioneering Approach To Futuristic Treatments!


image352

   June 2018 

The global genomics market size is expected to reach USD 27.6 billion by 2025, according to a new report by Grand View Research, Inc., progressing at a CAGR of 9.7% during the forecast period.

image353

 Published Date: Sep, 2018

Metagenomics Market Size, Share & Trends Analysis Report By Product (Sequencing & Data Analytics), By Technology (Sequencing, Function), By Application (Environmental), And Segment Forecasts, 2018 - 2025

Some of the prominent players operating in this market are Illumina, Inc.; Promega Corporation; Novogene Corporation; Oxford Gene Technology, Inc.; Thermo Fisher Scientific, Inc.; TAKARA BIO INC.; Danaher; QIAGEN; and ELITechGroup.